A Simple Step to Close a Dangerous Biosecurity Gap
NTI President and CEO Christine E. Wormuth joins fellow leaders in calling on U.S. policymakers to act with urgency and establish clear national standards for DNA synthesis screening.
Risky Business
Welcome to the blog
Here we highlight the work of NTI and share knowledge, ideas, and viewpoints addressing the crosscutting challenges our world faces—addressing risks while supporting innovation—to make our world safer.
Three Strikes: Why Giving Up on the NPT Is Not an Option
AIxBio Horizon Scan Finds Accelerating Capabilities Require Urgent Oversight
The Legacy of Ted Turner: “We all have a stake.”
What Would Make a New Iran Deal Better than the Last One?
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
The United States Must Lead in the Fight Against Coronavirus
Coronavirus Underscores Need for Urgent Action to Reduce Global Catastrophic Biological Risks
Coronavirus Underscores Need for Urgent Action to Reduce Global Catastrophic Biological Risks
Horsepox Research Accentuates Urgency for Global Action to Reduce Biological Risks
Horsepox Research Accentuates Urgency for Global Action to Reduce Biological Risks
Biosecurity Imperative: An Urgent Case for Extending the Global Health Security Agenda
Biosecurity Imperative: An Urgent Case for Extending the Global Health Security Agenda
Democratization of Synthetic Biology: Implications for Biosecurity and Pandemic Threats
Democratization of Synthetic Biology: Implications for Biosecurity and Pandemic Threats
70th World Health Assembly: Election of New Director General During Uncertain Times
Risky Business is edited by:
Scott Nolan Smith
Senior Director, Communications
Mary Olney Fulham
Director, Communications